September 13, 2021
Depression appeared to increase risk for incident vascular disease and mortality among individuals with MS, according to results of a population-based retrospective matched cohort study published in Neurology.
“In the general population, depression is associated with a 30% increased relative risk of developing vascular disease and a 70% increased relative risk of all-cause mortality,” Raffaele Palladino, MD, PhD, of the department of primary care and public health at Imperial College of London in the U.K., and colleagues wrote. “Moreover, the more severe the depression, the higher the risk of onset of vascular disease and associated mortality. However, much less is known about these associations in the MS population.”
Palladino and colleagues aimed to evaluate whether the links between depression, vascular disease and mortality differed among people with MS (n = 12,251) and a control cohort without MS (n = 72,572). Investigators matched participants according to age, sex and general practice site in England, then stratified patients by depression status. Patients in the MS cohort received diagnosis between Jan. 1, 1987, and Sept. 30, 2018. To evaluate the relationship between MS, depression and time to incident vascular disease and mortality, researchers used time-varying Cox proportional hazard regression models. They also stratified analyses by sex.
Results showed depression in 21% in the MS cohort and 9% in the control cohort. Those with MS had increased risk for incident vascular disease regardless of the presence of comorbid depression compared with matched control participants without depression. Palladino and colleagues noted 10-year risk for all-cause mortality was 1.75 times greater among controls with depression (95% CI, 1.59-1.91), 3.88 times greater among individuals with MS without depression (95% CI, 3.66-4.1) and 5.43 times greater among individuals with MS and depression (95% CI, 4.88-5.96). Further, they reported a synergistic interaction between MS and depression, with the interaction dictating 14% of the observed effect. They confirmed differences in hazard ratios via sex-stratified analyses.
Click HERE to Subscribe for the MS Beacon eNewsletter and database
|
